Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Last updated: August 13, 2025
Sponsor: Zydolab - Institute of Cytology and Immune Cytochemistry
Overall Status: Active - Recruiting

Phase

N/A

Condition

Warts

Treatment

Carbon dioxide Laser ablation

Electrocoagulation

Clinical Study ID

NCT02520986
CONDYLOMA-1
  • Ages > 18
  • Female

Study Summary

In a randomized clinical trial of 114 women undergoing Treatment for condyloma acuminata, two surgical methods, the carbon dioxide laser Ablation and the excision by electrocoagulation, will be compared. The primary outcome of the study is the cosmetic result judged by the Patient 6 weeks after Treatment using a 11-step visual analogue scale (VAS), secondary outcomes are intervention time, operative complications, subjects and users satisfaction, postoperative pain and recurrence of genital warts.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • informed consent

  • women with anogenital affection of condyloma acuminata

Exclusion

Exclusion Criteria:

  • significant language barrier

  • pregnancy

  • unwillingness to participate

  • the use of blood thinner or known coagulation disorder

  • the use of immunosuppressive medicament

  • HIV-Infection

  • malignant diseases

  • local therapy within 8 weeks before Treatment

  • wound healing disorder

Study Design

Total Participants: 114
Treatment Group(s): 2
Primary Treatment: Carbon dioxide Laser ablation
Phase:
Study Start date:
December 01, 2016
Estimated Completion Date:
December 01, 2026

Connect with a study center

  • Department of Obstetrics and Gynecology of the Ruhr University Bochum

    Herne, NRW 44625
    Germany

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.